A multicenter, open‐label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney–pancreas transplant recipients: interim analysis
Year: 2002
Type: article
Study design: Clinical Trial
Source: Clinical Transplantation
Authors: Robert J Stratta, Rita R Alloway, Ernest Hodge, Agnes Lo, for the Pancreas Investigators Vital Outcomes Trial (PIVOT) Study Group
Institution: University of Tennessee Health Science Center
Language: English
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2085206298